CHRN ChronoScale Holdings Corp
AI brief AI-written, not reviewed by a person
Latest filings show cash and equivalents at 15,221,000 USD as of 2026-08-31, up from 9,664,000 USD on 2026-05-31 and 3,993,000 USD on 2026-03-31. Stockholders’ equity is 150,650,000 USD at 2026-08-31, down from 180,025,000 USD on 2026-05-31 and higher earlier values; total assets are 295,405,000 USD at 2026-08-31, versus 325,874,000 USD on 2026-05-31. The latest year-reported diluted EPS (12 months to 2025-12-31) is -4.91 USD, improved from -8.43 USD for the 12 months to 2024-12-31.
- Cash and equivalents increased to 15,221,000 USD at 2026-08-31 from 9,664,000 USD at 2026-05-31 and 3,993,000 USD at 2026-03-31. [1]
- Stockholders’ equity was 150,650,000 USD at 2026-08-31, down from 180,025,000 USD at 2026-05-31. [1]
- Total assets were 295,405,000 USD at 2026-08-31, down from 325,874,000 USD at 2026-05-31. [1]
- Diluted EPS (year, 12 months to 2025-12-31) was -4.91 USD per share, improved from -8.43 USD per share for 12 months to 2024-12-31. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
What the sources did not support
- Some figures (e.g., long-term debt, operating cash flow, revenue) exist in the sources but were not used in the summary due to the instruction to only include figures directly comparable for the latest period versus prior period where explicitly provided.
- No explicit quarterly year-over-year comparison beyond the cited items was included.
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-08-31) | 41,482,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2026-05-31) | 71,604,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-08-31) | -42,484,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | -11,695,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-08-31) | -24,887,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | -13,326,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-08-31) | -0.29 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | -4.91 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-08-31) | 14,625,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | -11,801,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-08-31) | 295,405,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-08-31) | 144,755,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-08-31) | 150,650,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-08-31) | 15,221,000 USD | sec-companyfacts | current | ||
| Long-term debt (at 2026-08-31) | 151,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-13) | 145,637,452 shares | sec-companyfacts | current |
Context
No reviewed context has been published for CHRN. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add CHRN to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: CHRN.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.